Shao-Hsi Hung

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy

G. Lizée, Xia Bu, G. Freeman, 2023, Frontiers in immunology.